IDH2 and central nervous system cancer: In addition, overexpression of mutant IDH2 (R172G) in glioma cells induces nuclear accumulation of β-catenin and upregulation of HIF-1α (hypoxia-inducible factor-1α) signaling that were closely related with tumor invasion and chemoresistance [38].